Related Experiment Video
Updated: Jul 12, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Pharmacokinetic and pharmacodynamic variability as possible causes for different drug responses in migraine. A
1Danish Headache Centre, Depatment of Neurology, Glostrup Hospital, DK-2600 Glostrup, Denmark. tfelt@inet.uni2.dk
Abstract:
The pharmacokinetics of antimigraine drugs zolmitriptan and sumatriptan varied considerably with a fourfold to 10-fold variation in plasma levels. In addition, the pharmacodynamics of triptans as investigated in vitro also varied considerably. In theory, there should probably be a 10-fold variation in doses available, but in clinical practice a fourfold difference in doses will probably cover the needs of most patients.
Related Concept Videos
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Dosage Regimen: Individualization
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmacodynamic Responses: Different Types
Drug toxicity: Idiosyncratic Reactions
Pharmacogenetics of Drug Metabolism: Overview

